Skip to content

Assessment of platelet rich plasma injection in clinical outcome and MRI findings in patients with knee osteoarthritis

Assessment of platelet rich plasma intraarticular injection in clinical outcome and MRI findings in knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014020413442N6
Enrollment
40
Registered
2014-02-26
Start date
2013-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Gonarthrosis [arthrosis of knee]

Interventions

Intervention 1: Intervention group : platelet rich plasma, knee intraarticular injection, 4 to 6 milliliter, 2 times, 4 weeks interval. Intervention 2: Control group:exercise,quadriceps strengthening
Treatment - Drugs
Treatment - Other
Intervention group : platelet rich plasma, knee intraarticular injection, 4 to 6 milliliter, 2 times, 4 weeks interval
Control group:exercise,quadriceps strengthening and hamstring stretching,10 times for 10 seconds,3 times a day

Sponsors

Physical Medicine and Rehabilitation Department of Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: arthralgia since past 3 months; radiologic evidence of articular damage (grade 1-4 of Kellgren-Lawrence scale) based on knee OA criteria of ACR. Exclusion criteria: systemic diseases such as diabetes mellitus and collagen vascular disorders; history or presence of cancer or malignant disorders; any infection and active wound of the knee; presence of immunosuppressive, autoimmune and platelet disorders; treatment with anticoagulant and anti-platelet medications 10 days before injection; use of NSAIDs 2 days before injection; history of knee articular injections of corticosteroids 3 weeks or use of systemic corticosteroids 2 weeks before PRP injections; hemoglobin measures of less than 12 g/dl and platelet counts of less than 150,000 per micro liter; recent history of severe trauma to the knee; age less than 45 or over 75 year; history of vasovagal shock; pregnancy; breastfeeding; genu valgum/varum greater than 20 degrees; contraindication for MRI including aneurysm clips,pacemaker,metallic devices and claustrophobia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cartilage lesion. Timepoint: before intervention & 6 months after intervention. Method of measurement: WORMS criteria.;Joint stiffness. Timepoint: before intervention & 6 months after intervention. Method of measurement: WOMAC questionnaire.;Function. Timepoint: before intervention & 6 months after intervention. Method of measurement: WOMAC questionnaire.;Knee pain. Timepoint: before intervention & 6 months after intervention. Method of measurement: WOMAC questionnaire.;Knee pain. Timepoint: before intervention & 6 months after intervention. Method of measurement: VAS.;Bone marrow edema. Timepoint: before intervention & 6 months after intervention. Method of measurement: WORMS criteria.;Meniscus lesion. Timepoint: before intervention & 6 months after intervention. Method of measurement: WORMS criteria.;Synovitis. Timepoint: before intervention & 6 months after intervention. Method of measurement: WORMS criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Ghorbani

Shahid modarres hospital

e_ghorbani@sbmu.ac.ir+98 21 2207 4090

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026